A prospective, randomized, open-blinded endpoint (PROBE) trial for safety of oral apixaban vs subcutaneous enoxaparin for thromboprophylaxis in women with a suspected gynecologic malignancy

Saved in:

Bibliographic Details
Published in:	Gynecologic oncology Vol. 145; pp. 55 - 56
Main Authors:	Guntupalli, S.R, Brennecke, A, Sheeder, J, Cheng, G, Behbakht, K, Babayan, L.M, Corr, B.R, Lefkowits, C, Matsuo, K, Flink, D.M
Format:	Journal Article
Language:	English
Published:	01-06-2017
Subjects:	Hematology, Oncology and Palliative Medicine Obstetrics and Gynecology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0090-8258
DOI:	10.1016/j.ygyno.2017.03.136